Clinical Reference Laboratory Inc to build European laboratory hub in UK
Clinical Reference Laboratory Inc has concluded a deal with Quotient Bioresearch that will see CRL Global services establish its new European laboratory hub in the UK. CRL Global Services has a track record of more than 18 years in delivering testing services to support clinical development programs in the pharmaceutical, biotechnology and CRO industries. Entering in to this agreement marks a clear strategic shift – to move away from the company’s earlier partnership within Europe.
CRL Global Services has chosen to construct its own laboratory in Cambridgeshire, UK, embedded within the existing facilities of Quotient Bioresearch. It will provide a further full service laboratory arm to CRL Global Services’ existing global structure. The contract also provides for an immediate close collaboration between the companies on the development and delivery of new services, particularly in the areas of bioanalysis, biomarkers and microbiology.
Leader of the organisation for more than 10 years, Rajani Prasad, PhD, vice president, clinical trials and Arnold Verbeek, PhD, general manager of Clinical Reference Laboratory – Europe Ltd, commented: “Our agreement with Quotient Bioresearch signals a new chapter in CRL’s development. We are confident that by using our own operations and applying our technology on a global scale CRL guarantees clients the most streamlined, highest quality and best value available in clinical trials support.”
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
The evolution of cancer cells decoded - "Our vision is a new type of early cancer detection"
Protagen Deepens Cooperation With Bayer Schering Pharma
Seeing a diagnosis: How an eye test could aid Alzheimer's detection
C-mo Medical Solutions raises €4.1 million aiming to transform cough monitoring
New technique for testing drugs to treat cystic fibrosis and epilepsy
Neuronal Parkinson inclusions are different than expected - Study raises new questions about the etiology of Parkinson’s disease
Analytik Jena Sells Site in Eisfeld - New investor acquiring entire Optics business unit as well as component production for analytical technology
Toxic agents behind Parkinson's disease seen at work for the first time - First look at how toxic protein clusters disrupt the membranes of healthy brain cells.
Ocean Optics Employee Wins Global Technology Award - Nelson Chandler takes £20K top prize from multi-national technology company
Measuring the magnetism of antimatter - Researchers measure antiprotons more accurately than ever before
KRÜSS is one of the innovation leaders in 2018 - TOP 100 competition success
